Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Atara Biotherapeutics, Inc. ATRA

Full chart Compare
Set alert

Price alert · ATRA

All alert types
8.38 USD +0.18 (+2.20%)

Nov 4, 2026, 1:56 PM EST

8.37 Day range 8.53
3.92 52-week range 19.15
YTD
-53.68%
1 year
-31.81%

Financial health

Altman Z-Score

-135.88 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E 6.9×
FY 2016: -5.2×FY 2017: -4.5×FY 2018: -6.6×FY 2019: -2.9×FY 2020: -4.7×FY 2021: -4.3×FY 2022: -1.5×FY 2023: -0.2×FY 2024: -1.2×FY 2025: 6.9×
FY 2016 5y median -1.2× FY 2025
P/S 1.9×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 72.6×FY 2022: 5.3×FY 2023: 6.3×FY 2024: 0.8×FY 2025: 1.9×
FY 2016 5y median 5.3× FY 2025
P/B -5.9×
FY 2016: 1.6×FY 2017: 3.0×FY 2018: 4.5×FY 2019: 2.9×FY 2020: 3.1×FY 2021: 5.3×FY 2022: 2.6×FY 2023: -0.5×FY 2024: -1.0×FY 2025: -5.9×
FY 2016 5y median -0.5× FY 2025
P/FCF -4.5×
FY 2016: -6.5×FY 2017: -5.0×FY 2018: -7.1×FY 2019: -3.5×FY 2020: -7.8×FY 2021: -6.4×FY 2022: -1.2×FY 2023: -0.3×FY 2024: -1.4×FY 2025: -4.5×
FY 2016 5y median -1.4× FY 2025
EV/EBITDA 7.0×
FY 2016: -4.5×FY 2017: -3.8×FY 2018: -6.3×FY 2019: -2.7×FY 2020: -4.2×FY 2021: -4.2×FY 2022: -1.4×FY 2023: -0.3×FY 2024: -1.6×FY 2025: 7.0×
FY 2016 5y median -1.4× FY 2025
EV/Sales 2.2×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 68.8×FY 2022: 4.9×FY 2023: 10.1×FY 2024: 0.9×FY 2025: 2.2×
FY 2016 5y median 4.9× FY 2025
FCF Yield -22.4%
FY 2016: -15.5%FY 2017: -19.9%FY 2018: -14.2%FY 2019: -28.6%FY 2020: -12.8%FY 2021: -15.7%FY 2022: -82.1%FY 2023: -357.6%FY 2024: -69.2%FY 2025: -22.4%
FY 2016 5y median -69.2% FY 2025

Profitability

Gross Margin 82.4%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -1286.4%FY 2022: -324.7%FY 2023: -3.7%FY 2024: 83.7%FY 2025: 82.4%
FY 2016 5y median -3.7% FY 2025
Operating Margin 29.7%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -1673.9%FY 2022: -441.2%FY 2023: -3219.5%FY 2024: -64.7%FY 2025: 29.7%
FY 2016 5y median -441.2% FY 2025
Net Margin 27.1%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -1672.3%FY 2022: -359.1%FY 2023: -3220.9%FY 2024: -66.2%FY 2025: 27.1%
FY 2016 5y median -359.1% FY 2025
ROE -84.9%
FY 2016: -311.5%FY 2017: -671.8%FY 2018: -680.8%FY 2019: -100.1%FY 2020: -66.3%FY 2021: -121.6%FY 2022: -180.3%FY 2023: 278.3%FY 2024: 87.8%FY 2025: -84.9%
FY 2016 5y median -84.9% FY 2025
ROIC 222.7%
FY 2016: -32.0%FY 2017: -63.9%FY 2018: -67.3%FY 2019: -96.1%FY 2020: -60.9%FY 2021: -93.3%FY 2022: -90.2%FY 2023: -778.4%FY 2024: 721.7%FY 2025: 222.7%
FY 2016 5y median -90.2% FY 2025
ROA 161.5%
FY 2016: -299.5%FY 2017: -548.7%FY 2018: -588.8%FY 2019: -84.8%FY 2020: -52.1%FY 2021: -72.7%FY 2022: -60.7%FY 2023: -166.8%FY 2024: -78.3%FY 2025: 161.5%
FY 2016 5y median -72.7% FY 2025

Growth (YoY)

Revenue -6.3%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 212.6%FY 2023: -86.5%FY 2024: 1404.0%FY 2025: -6.3%
FY 2016 FY 2025
Operating Income 143.0%
FY 2016: -39.0%FY 2017: -49.6%FY 2018: -95.1%FY 2019: -24.7%FY 2020: -4.5%FY 2021: -10.2%FY 2022: 17.6%FY 2023: 1.6%FY 2024: 69.8%FY 2025: 143.0%
FY 2016 FY 2025
EPS (diluted) 122.5%
FY 2016: -23.0%FY 2017: -45.4%FY 2018: -31.6%FY 2019: -7.7%FY 2020: 26.9%FY 2021: 12.4%FY 2022: 38.4%FY 2023: -16.5%FY 2024: 82.5%FY 2025: 122.5%
FY 2016 FY 2025
Free Cash Flow 26.1%
FY 2016: -68.4%FY 2017: -70.9%FY 2018: -100.2%FY 2019: -11.9%FY 2020: 23.2%FY 2021: -24.7%FY 2022: -18.8%FY 2023: 29.3%FY 2024: 64.5%FY 2025: 26.1%
FY 2016 FY 2025

Financial Health

Current Ratio 0.8×
FY 2016: 26.9×FY 2017: 6.2×FY 2018: 8.0×FY 2019: 7.4×FY 2020: 6.3×FY 2021: 3.6×FY 2022: 3.7×FY 2023: 0.7×FY 2024: 0.5×FY 2025: 0.8×
FY 2016 5y median 0.8× FY 2025
Quick Ratio 0.8×
FY 2016: 26.9×FY 2017: 6.2×FY 2018: 8.0×FY 2019: 7.4×FY 2020: 6.3×FY 2021: 3.6×FY 2022: 3.7×FY 2023: 0.6×FY 2024: 0.4×FY 2025: 0.8×
FY 2016 5y median 0.8× FY 2025
Debt / Equity -1.4×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 0.1×FY 2022: 0.6×FY 2023: -0.6×FY 2024: -0.5×FY 2025: -1.4×
FY 2016 5y median -0.5× FY 2025
Net Debt / EBITDA 1.1×
FY 2016: 0.6×FY 2017: 0.7×FY 2018: 0.3×FY 2019: 0.2×FY 2020: 0.6×FY 2021: 0.2×FY 2022: 0.1×FY 2023: -0.1×FY 2024: -0.2×FY 2025: 1.1×
FY 2016 5y median 0.1× FY 2025
Interest Coverage 9.5×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -752×FY 2023: -52.2×FY 2024: -18.1×FY 2025: 9.5×
FY 2016 5y median -18.1× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31